Physician profile
Nicholas Liaw
NPI 1437543345
$6,378.78
in general payments reported to CMS, 2019-2025
18 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.84 · 2021: $2,428 · 2022: $3,083 · 2023: $266 · 2024: $59.48 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,100.76 | 2022 | |
| Stryker Corporation | $2,099.13 | 2021-2025 | Trevo, Universal Neuro 3, Neuroform Atlas |
| Depuy Synthes Sales INC. | $624.26 | 2021-2025 | Trufill, Embotrap, Emboguard |
| Penumbra, INC. | $369.02 | 2020-2025 | Penumbra System |
| Imperative Care, INC | $326.50 | 2021-2024 | Zoom 88-T Large Distal Platform |
| Medtronic, INC. | $270.61 | 2021-2022 | |
| Phenox INC. | $196.16 | 2022 | |
| Alexion Pharmaceuticals, INC. | $111.75 | 2021 | |
| Abbvie INC. | $50.60 | 2021-2022 | |
| Integra Lifesciences Corporation | $44.65 | 2022 | |
| Microvention, INC. | $36.31 | 2023 | Web Aneurysm Embolization System |
| Bioventus LLC | $33.55 | 2022 | |
| Acadia Pharmaceuticals INC | $25.15 | 2025 | Nuplazid |
| Livanova USA, INC. | $22.92 | 2020 | |
| Route 92 Medical, INC. | $22.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $17.53 | 2021 | |
| Nevro Corp. | $16.00 | 2021 | |
| Angiodynamics, INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Liaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.